@article{4c63e4ab283c43a8aa64807bcfbd37bb,
title = "WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry",
author = "Schl{\"a}epfer, \{Thomas E.\} and George, \{Mark S.\} and Helen Mayberg",
note = "Funding Information: Dr George has no equity ownership in any device or pharmaceutical company and his total industry-related compensation per year is less than 10\% of his university salary. His institution, MUSC has filed eight patents or invention disclosures in his name regarding brain imaging and stimulation. He is the study chair of a large NIMH sponsored trial of TMS in depression (called OPT-TMS) and is on the executive committee of a large veterans administration (VA) trial of TMS in Depression (CSP\#556). He thus has received no compensation from any TMS manufacturer for the last 4 years, but is an unpaid consultant to Neuronetics, Brainsway, and Neostim, as well as PureTech Ventures. MUSC is a site in a multisite Brainsway sponsored trial. Neu-ronetics has donated equipment for an investigator initiated VA trial of TMS in acute suicide. Dr George has been a paid consultant or received research grants from Cyberonics (VNS) and Neuropace (DBS), but not in the past year. Medtronic donated equipment for an investigator-initiated trial of epidural cortical stimulation conducted at MUSC (PI, Dr Nahas). Within the past 3 years he has received industry support for two TMS studies investigating the effects of medications on brain excitability (Jazz pharmaceuticals, Glaxo Smith Kline). He is the editor in chief of an Elsevier sponsored journal, Brain Stimulation. He is currently funded by NIMH, NIDA, VA and DOD.",
year = "2010",
doi = "10.3109/15622970903170835",
language = "English",
volume = "11",
pages = "2--18",
journal = "World Journal of Biological Psychiatry",
issn = "1562-2975",
publisher = "Taylor and Francis Ltd.",
number = "1",
}